pyrazolanthrone has been researched along with Anasarca in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Altavilla, D; Bitto, A; Famulari, C; Macrì, A; Marini, H; Minutoli, L; Passaniti, M; Seminara, P; Squadrito, F; Venuti, FS; Versaci, A | 1 |
1 other study(ies) available for pyrazolanthrone and Anasarca
| Article | Year |
|---|---|
Protective effects of SP600125 a new inhibitor of c-jun N-terminal kinase (JNK) and extracellular-regulated kinase (ERK1/2) in an experimental model of cerulein-induced pancreatitis.
Topics: Amylases; Analysis of Variance; Animals; Anthracenes; Blotting, Western; Ceruletide; Disease Models, Animal; Edema; Enzyme Activation; Histological Techniques; Intercellular Adhesion Molecule-1; JNK Mitogen-Activated Protein Kinases; Lipase; Male; MAP Kinase Kinase 4; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinase Kinases; Oligonucleotides; Pancreas; Pancreatitis; Peroxidase; Reverse Transcriptase Polymerase Chain Reaction; RNA; Signal Transduction; Tumor Necrosis Factor-alpha | 2004 |